Virus Research

Papers
(The H4-Index of Virus Research is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection146
Classical swine fever virus: the past, present and future104
The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta99
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-1997
Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil93
Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis73
The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review71
The virology of human monkeypox virus (hMPXV): A brief overview56
The role of dysregulated immune responses in COVID-19 pathogenesis55
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines53
Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant53
Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-250
Association of vitamin D with the modulation of the disease severity in COVID-1949
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review49
Ozone therapy in COVID-19: A narrative review49
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection43
Nitric oxide (NO) and nanoparticles – Potential small tools for the war against COVID-19 and other human coronavirus infections41
Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity41
CRISPR systems: Novel approaches for detection and combating COVID-1940
DEAD/H-box helicases:Anti-viral and pro-viral roles during infections37
Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world36
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-1935
Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?34
Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential33
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects32
Dengue virus infection – a review of pathogenesis, vaccines, diagnosis and therapy31
Evidence supporting a viral origin of the eukaryotic nucleus31
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models30
Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint30
The role of circular RNAs in viral infection and related diseases29
SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves29
Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes29
"Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit"29
Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo29
0.065216064453125